Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Combinations of Anti-HIV Drugs Increasing : JSAR Meeting
December 27, 2004
- BUSINESS NEWS IN BRIEF
December 27, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 27, 2004
- Press Seminar
December 27, 2004
- GL Prepared for Use of Thalidomide for Multiple Myeloma
December 27, 2004
- Mixed Medical Care to Be Expanded
December 27, 2004
- OTC NEWS IN BRIEF
December 27, 2004
- List of Institutions Which Received Delivery of MPC's Fibrinogen Preparations Published
December 27, 2004
- JSGM to Introduce GE Information System on Full Scale in April
December 27, 2004
- REGULATORY NEWS IN BRIEF
December 27, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 27, 2004
- NEW PRODUCTS
December 27, 2004
- Website News
December 27, 2004
- Base Sequences Predict Iressa Adverse Reactions: IMSUT Group
December 27, 2004
- Fujirebio, SRL to Consolidate in April 2005
December 27, 2004
- 2004 Spot Test Market Totals \94.4 Bil. in 2003: Fuji-keizai
December 27, 2004
- MEDICAL DEVICE NEWS IN BRIEF
December 27, 2004
- Astellas Pharma to Explore Any Possibility to Become a Global Mega Pharma
December 27, 2004
- Norvasc Ranked at Top in 3rd Qtr: IMS Data
December 27, 2004
- Semi-annual Business Results
December 20, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…